Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Reddit Inc (RDDT) vs Twist Bioscience Corp (TWST) Price & Performance

Reddit IncTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Reddit Inc vs Twist Bioscience Corp — how do they compare? Reddit Inc trades at $159.65 (market cap $30.10B), while Twist Bioscience Corp trades at $160.35 (market cap $10.08B). The key difference: Reddit Inc is far larger — about 3× Twist Bioscience Corp's market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Reddit Inc for 26 Days and Twist Bioscience Corp for 27 Days on average.

RDDTTWST
Market Cap
$30.10B$10.08B
Volume
4,560,4404,229,037
Sector
MediaHealth
52-Week High
$258.93$205.00
52-Week Low
$121.84$25.45
Typical Hold Time
26 Days27 Days
Enterprise Value
$27.34B$10.01B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Reddit Inc

Reddit (RDDT) trades at $159.84, up 4.63% today, showing strong momentum after three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $160. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, while revenue growth accelerated to $2.8 billion in 2026. Recent developments include a strategic partnership with Zefr for AI-powered advertising solutions and expanding international revenues by 84%.

The investment outlook remains positive with 65.5% analyst buy ratings and a $202.52 consensus price target representing 27% upside potential. Key opportunities include continued AI data licensing growth and international expansion, while risks involve competitive pressure from Meta and regulatory concerns. The stock's premium valuation at 36.4x P/E requires sustained execution to justify current levels.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $159.78, up 2.65% today, showing strong momentum despite mixed technical signals. The company continues to demonstrate robust revenue growth, with 2025 revenue reaching $377 million, though profitability remains elusive with a -31.66% net income margin. Recent positive developments include a strategic partnership with Eli Lilly's TuneLab AI platform announced September 16, 2026, driving investor optimism about the company's AI-driven drug discovery capabilities.

While analyst consensus remains bullish with 73% buy ratings, the stock faces significant fundamental challenges including persistent cash burn and negative earnings. The current price exceeds the $145.20 consensus target, suggesting limited near-term upside. Key risks include execution challenges in achieving profitability and dependence on AI partnerships for growth catalysts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

RDDT
43% Buy57% Sell
Avg holding period · 26 Days
TWST
100% Buy0% Sell
Avg holding period · 27 Days

Top news

Latest headlines on both assets

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT →

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST →